instruction stringlengths 225 2.35k | input stringlengths 89 1.5k | response stringclasses 698 values |
|---|---|---|
<Instruct>: Given the context 'When challenged with 2 × 107 CFU/mouse by the i.p. route, loss of T cells resulted in reduced survival (50%) relative to the non-specific isotype control (Fig. 2).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: mouse (aka mus <genus>)
C: mus sp. (mice (aka mus sp.))
D: eastern european house mouse (aka mus musculus musculus)
E: None of the above. | [E] |
<Instruct>: Given the context 'To further evaluate the necessity of these effector cells in providing protection following HK vaccination, relatively resistant C57BL/6 mice, deficient in mature B-cells (μMT), CD4 T-cells (CD4-/-) or CD8 T-cells (CD8-/-) were subjected to an identical HK vaccination and challenge regimen.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mouse (aka mus musculus)
B: mus castaneus (aka mus musculus castaneus)
C: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
D: eastern european house mouse (aka mus musculus musculus)
E: peromyscus
F: None of the above. | [A] |
<Instruct>: Given the context 'Mature, B-cell-deficient mice demonstrated a 50% decreased survival (p = 0.0888) compared to the wild-type mice with an MST of 35.5 days (Fig. 3).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus castaneus (aka mus musculus castaneus)
B: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
C: mouse (aka mus musculus)
D: mus cricetus (aka cricetus cricetus)
E: mus sp. (mice (aka mus sp.))
F: None of the above. | [C] |
<Instruct>: Given the context 'CD4-/- and CD8-/- mice exhibited a 60% (p = 0.1343) and 0% reduced survival, respectively (Fig. 3).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus castaneus (aka mus musculus castaneus)
B: western european house mouse (aka mus musculus domesticus)
C: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
D: house mouse (aka mus musculus)
E: mouse (aka mus <genus>)
F: None of the above. | [D] |
<Instruct>: Given the context 'Effects of cytokine depletion on HK vaccination
Similar studies were performed to determine the role of IFN-γ or TNF-α in acute infection in BALB/c mice immunized with HK bacteria.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
B: eastern european house mouse (aka mus musculus musculus)
C: mus castaneus (aka mus musculus castaneus)
D: mus <subgenus> (mus (aka mus <subgenus>))
E: mouse (aka mus musculus)
F: None of the above. | [E] |
<Instruct>: Given the context 'Six hours before challenge, mice were dosed with antibodies that neutralize IFN-γ or TNF-α.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus castaneus (aka mus musculus castaneus)
B: mouse (aka mus musculus)
C: mus (aka mus <genus>) (aka mus <genus>)
D: mus sp. (mice (aka mus sp.))
E: peromyscus
F: None of the above. | [B] |
<Instruct>: Given the context 'Individual depletion of either TNF-α (p = 0.0145) or IFN-γ (p = 0.0446) resulted in 100% mortality with an MST of 3 and 2 days, respectively, compared to the HK-vaccinated isotype control mice (Fig. 4).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus castaneus (aka mus musculus castaneus)
B: mouse (aka mus musculus)
C: mice (aka mus <genus>) (aka mus <genus>)
D: peromyscus
E: eastern european house mouse (aka mus musculus musculus)
F: None of the above. | [B] |
<Instruct>: Given the context 'In contrast, 40% of HK-vaccinated, isotype control mice survived to at least 12 days post-challenge (Fig 4).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: peromyscus
B: mus castaneus (aka mus musculus castaneus)
C: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
D: mus musculus (house mouse) (aka mus musculus)
E: mus cricetus (aka cricetus cricetus)
F: None of the above. | [D] |
<Instruct>: Given the context 'To further evaluate the host TNF-α response during an established B. mallei chronic infection, we infected 12 BALB/c mice by the i.p. route with 1 × 106 CFU B. mallei.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei; mice]
<Options>: A: mus sp. (mice (aka mus sp.))
B: mus musculus (house mouse) (aka mus musculus)
C: modicella malleola (endogone malleola) (aka modicella malleola)
D: mus <subgenus> (mus (aka mus <subgenus>))
E: malleomyces mallei (aka burkholderia mallei)
F: erysiphe malloti
G: mucilaginibacter mallensis
H: mus cricetus (aka cricetus cricetus)
I: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
J: 'bartonella melophagi' (aka bartonella melophagi)
K: None of the above. | [E; B] |
<Instruct>: Given the context 'To further evaluate the host TNF-α response during an established B. mallei chronic infection, we infected 12 BALB/c mice by the i.p. route with 1 × 106 CFU B. mallei.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei; mice]
<Options>: A: mus (aka mus <genus>) (aka mus <genus>)
B: mucilaginibacter mallensis
C: malleomyces pseudomallei (aka burkholderia pseudomallei)
D: mus (aka mus <subgenus>) (aka mus <subgenus>)
E: mallomonas peronoides (aka mallomonas peroneides)
F: mus domesticus (aka mus musculus domesticus)
G: acinetobacter mallei (aka burkholderia mallei)
H: mouse (aka mus musculus)
I: mus cricetus (aka cricetus cricetus)
J: erysiphe malloti
K: None of the above. | [G; H] |
<Instruct>: Given the context 'On day 42 post-infection, the remaining 11 mice were dosed with either anti-TNF-α (n = 6), or control mAb (AFRC Mac 49) (n = 5).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: eastern european house mouse (aka mus musculus musculus)
C: house mouse (aka mus musculus)
D: mus (aka mus <subgenus>) (aka mus <subgenus>)
E: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
F: None of the above. | [C] |
<Instruct>: Given the context 'No further deaths were observed in the control mAb-treated mice.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus musculus (house mouse) (aka mus musculus)
B: mus <subgenus> (mus (aka mus <subgenus>))
C: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
D: mus cricetus (aka cricetus cricetus)
E: mus castaneus (aka mus musculus castaneus)
F: None of the above. | [A] |
<Instruct>: Given the context 'Rapid mortality was observed in the anti-TNF-α-treated group, with all mice dying within 7 days of treatment (p = 0.0023) relative to the isotype-treated controls (Fig. 5).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
C: mus musculus (house mouse) (aka mus musculus)
D: mus castaneus (aka mus musculus castaneus)
E: mus sp. (mice (aka mus sp.))
F: None of the above. | [C] |
<Instruct>: Given the context 'J774A.1 uptake of serum treated B. mallei
Complement mediated uptake assays were performed to evaluate opsonization.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: erysiphe malloti
B: modicella malleola (endogone malleola) (aka modicella malleola)
C: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
D: mallomonas papillosa
E: acinetobacter mallei (aka burkholderia mallei)
F: None of the above. | [E] |
<Instruct>: Given the context 'Results indicated enhanced bacterial uptake in J774A.1 phagocytes inoculated with serum treated B. mallei (p = .0082), compared to B. mallei alone, while heat-inactivated serum produced uptake percentages similar to those prior to serum addition (Fig. 6).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleomyces pseudomallei (aka burkholderia pseudomallei)
B: modicella malleola (endogone malleola) (aka modicella malleola)
C: mallomonas papillosa
D: malleco
E: malleomyces mallei (aka burkholderia mallei)
F: None of the above. | [E] |
<Instruct>: Given the context 'Immunoglobulin production in HK vaccinated BALB/c mice
We further characterized the ability of HK vaccination to induce a predominant IgG isotype by determining IgG2a/IgG1 ratios in i.p. and i.n. vaccinated BALB/c mice.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
B: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
C: mus (aka mus <genus>) (aka mus <genus>)
D: mus <subgenus> (mus (aka mus <subgenus>))
E: mus musculus (house mouse) (aka mus musculus)
F: None of the above. | [E] |
<Instruct>: Given the context 'Discussion
Recent studies have shown a key role in protection from lethal challenge for IFN-γ in non-vaccinated mice from either NK and/or NKT cells following experimental exposure to B. mallei and B. pseudomallei [7,8].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei; b. pseudomallei]
<Options>: A: burkholderia pseudomallei 5(1949)
B: burkholderia pseudomallei the (burkholderia pseudomallei strain the) (aka burkholderia pseudomallei the)
C: mouse (aka mus musculus)
D: burkholderia pseudomallei bdu 2
E: mus cricetus (aka cricetus cricetus)
F: erysiphe malloti
G: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
H: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
I: bacterium whitmori (aka burkholderia pseudomallei)
J: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
K: actinobacillus mallei (aka burkholderia mallei)
L: mucilaginibacter mallensis
M: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
N: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
O: malleco
P: None of the above. | [C; K; I] |
<Instruct>: Given the context 'Discussion
Recent studies have shown a key role in protection from lethal challenge for IFN-γ in non-vaccinated mice from either NK and/or NKT cells following experimental exposure to B. mallei and B. pseudomallei [7,8].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei; b. pseudomallei]
<Options>: A: burkholderia pseudomallei 5(1949)
B: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
C: mucilaginibacter mallensis
D: mouse (aka mus musculus)
E: mus cricetus (aka cricetus cricetus)
F: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
G: burkholderia pseudomallei the (burkholderia pseudomallei strain the) (aka burkholderia pseudomallei the)
H: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
I: burkholderia pseudomallei bdu 2
J: malleco
K: erysiphe malloti
L: actinobacillus mallei (aka burkholderia mallei)
M: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
N: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
O: None of the above. | [D; L; O] |
<Instruct>: Given the context 'Discussion
Recent studies have shown a key role in protection from lethal challenge for IFN-γ in non-vaccinated mice from either NK and/or NKT cells following experimental exposure to B. mallei and B. pseudomallei [7,8].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei; b. pseudomallei]
<Options>: A: bacillus pseudomallei (aka burkholderia pseudomallei)
B: malleco
C: modicella malleola (endogone malleola) (aka modicella malleola)
D: burkholderia pseudomallei-like species (aka burkholderia thailandensis)
E: burkholderia pseudomallei strain cb (aka burkholderia pseudomallei cb)
F: mus musculus (house mouse) (aka mus musculus)
G: eastern european house mouse (aka mus musculus musculus)
H: burkholderia pseudomallei the (burkholderia pseudomallei strain the) (aka burkholderia pseudomallei the)
I: mus sp. (mice (aka mus sp.))
J: mallomonas papillosa
K: mus <subgenus> (mus (aka mus <subgenus>))
L: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
M: burkholderia pseudomallei 6(1960)
N: mucilaginibacter mallensis
O: bacillus mallei (aka burkholderia mallei)
P: None of the above. | [F; O; A] |
<Instruct>: Given the context 'Discussion
Recent studies have shown a key role in protection from lethal challenge for IFN-γ in non-vaccinated mice from either NK and/or NKT cells following experimental exposure to B. mallei and B. pseudomallei [7,8].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei; b. pseudomallei]
<Options>: A: peromyscus
B: mallomonas peronoides (aka mallomonas peroneides)
C: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
D: mallomonas papillosa
E: burkholderia pseudomallei the (burkholderia pseudomallei strain the) (aka burkholderia pseudomallei the)
F: pseudomonas pseudomallei (aka burkholderia pseudomallei)
G: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
H: erysiphe malloti
I: burkholderia pseudomallei 5(1949)
J: burkholderia pseudomallei-like species (aka burkholderia thailandensis)
K: house mouse (aka mus musculus)
L: inocybe subg. mallocybe (aka mallocybe)
M: mice (aka mus sp.) (aka mus sp.)
N: loefferella mallei (aka burkholderia mallei)
O: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
P: None of the above. | [K; N; F] |
<Instruct>: Given the context 'A similar protective role in the innate response to infection has been demonstrated for TNF-α in B. pseudomallei infection [8].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: burkholderia pseudomallei strain the (aka burkholderia pseudomallei the)
B: burkholderia pseudomallei os (burkholderia pseudomallei strain os) (aka burkholderia pseudomallei os)
C: malleomyces pseudomallei (aka burkholderia pseudomallei)
D: burkholderia pseudomallei bdu 2
E: pseudomallei group
F: None of the above. | [C] |
<Instruct>: Given the context 'The studies presented here are consistent with the essential role of these factors in the relative levels of protection conferred by vaccination with heat-killed B. pseudomallei and would appear to be viable early markers for protection from lethal acute infection [9].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
B: burkholderia pseudomallei (loefflerella pseudomallei) (aka burkholderia pseudomallei)
C: burkholderia pseudomallei cb (burkholderia pseudomallei strain cb) (aka burkholderia pseudomallei cb)
D: burkholderia pseudomallei strain the (aka burkholderia pseudomallei the)
E: pseudomallei group
F: None of the above. | [B] |
<Instruct>: Given the context 'Currently, there are no fully protective vaccines against B. mallei or B. pseudomallei in a murine model, particularly for the sensitive BALB/c versus C57BL6 models.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei; b. pseudomallei; murine]
<Options>: A: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
B: pfeifferella mallei (aka burkholderia mallei)
C: burkholderia pseudomallei strain cb (aka burkholderia pseudomallei cb)
D: mus <subgenus> (mus (aka mus <subgenus>))
E: house mouse (aka mus musculus)
F: western european house mouse (aka mus musculus domesticus)
G: burkholderia pseudomallei bdu 2
H: 'bartonella melophagi' (aka bartonella melophagi)
I: mus norvegicus (aka rattus norvegicus)
J: burkholderia pseudomallei 5(1949)
K: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
L: malleomyces pseudomallei (aka burkholderia pseudomallei)
M: mus sp. (mice (aka mus sp.))
N: erysiphe malloti
O: None of the above. | [B; L; E] |
<Instruct>: Given the context 'Currently, there are no fully protective vaccines against B. mallei or B. pseudomallei in a murine model, particularly for the sensitive BALB/c versus C57BL6 models.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei; b. pseudomallei; murine]
<Options>: A: burkholderia pseudomallei strain the (aka burkholderia pseudomallei the)
B: burkholderia pseudomallei 5(1949)
C: burkholderia pseudomallei bdu 2
D: mus musculus (house mouse) (aka mus musculus)
E: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
F: mallomonas papillosa
G: mucilaginibacter mallensis
H: mouse (aka mus <genus>)
I: malleomyces mallei (aka burkholderia mallei)
J: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
K: mus sp. (mice (aka mus sp.))
L: mus (aka mus <subgenus>) (aka mus <subgenus>)
M: mus cricetus (aka cricetus cricetus)
N: malleomyces pseudomallei (aka burkholderia pseudomallei)
O: None of the above. | [I; N; D] |
<Instruct>: Given the context 'Currently, there are no fully protective vaccines against B. mallei or B. pseudomallei in a murine model, particularly for the sensitive BALB/c versus C57BL6 models.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei; b. pseudomallei; murine]
<Options>: A: peromyscus
B: bartonella melophagi (candidatus bartonella melophagi) (aka bartonella melophagi)
C: inocybe subg. mallocybe (aka mallocybe)
D: mus cricetus (aka cricetus cricetus)
E: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
F: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
G: pfeifferella mallei (aka burkholderia mallei)
H: burkholderia pseudomallei 5(1949)
I: mouse (aka mus musculus)
J: pseudomallei group
K: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
L: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
M: mucilaginibacter mallensis
N: burkholderia pseudomallei bdu 2
O: loefflerella pseudomallei (aka burkholderia pseudomallei)
P: None of the above. | [G; O; I] |
<Instruct>: Given the context 'Previous studies have also demonstrated that both the humoral and cell-mediated arms are essential for protection from B. pseudomallei infection [10].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: burkholderia pseudomallei 6(1960)
B: burkholderia pseudomallei strain os (aka burkholderia pseudomallei os)
C: bacterium whitmori (aka burkholderia pseudomallei)
D: burkholderia pseudomallei 5(1949)
E: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
F: None of the above. | [C] |
<Instruct>: Given the context 'Thus, loss or reduction of TNF-α and IFN-γ levels result in significantly reduced survival rates, substantiating previous reports of the role of these factors in protection against B. mallei [7].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: bacillus mallei (aka burkholderia mallei)
B: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
C: mallomonas papillosa
D: erysiphe malloti
E: bartonella melophagi (candidatus bartonella melophagi) (aka bartonella melophagi)
F: None of the above. | [A] |
<Instruct>: Given the context 'Moreover, we demonstrate a role for sustained TNF-α production in the maintenance of host survival throughout the course of B. mallei infection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleomyces pseudomallei (aka burkholderia pseudomallei)
B: pfeifferella mallei (aka burkholderia mallei)
C: erysiphe malloti
D: mallomonas papillosa
E: malleco
F: None of the above. | [B] |
<Instruct>: Given the context 'Moreover, we demonstrate a role for sustained TNF-α production in the maintenance of host survival throughout the course of B. mallei infection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleco
B: malleomyces pseudomallei (aka burkholderia pseudomallei)
C: erysiphe malloti
D: mallomonas papillosa
E: None of the above. | [E] |
<Instruct>: Given the context 'Mice with an established B. mallei chronic infection rapidly lost the ability to control the growth of the bacillus upon neutralization of TNF-α.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: mucilaginibacter mallensis
B: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
C: house mouse (aka mus musculus)
D: bacillus mallei (aka burkholderia mallei)
E: modicella malleola (endogone malleola) (aka modicella malleola)
F: peromyscus
G: western european house mouse (aka mus musculus domesticus)
H: malleco
I: erysiphe malloti
J: mus <subgenus> (mus (aka mus <subgenus>))
K: None of the above. | [C; D] |
<Instruct>: Given the context 'Mice with an established B. mallei chronic infection rapidly lost the ability to control the growth of the bacillus upon neutralization of TNF-α.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: mice (aka mus <genus>) (aka mus <genus>)
C: acinetobacter mallei (aka burkholderia mallei)
D: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
E: malleco
F: bartonella melophagi (candidatus bartonella melophagi) (aka bartonella melophagi)
G: mus musculus (house mouse) (aka mus musculus)
H: erysiphe malloti
I: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
J: mallomonas papillosa
K: None of the above. | [G; C] |
<Instruct>: Given the context 'Additional studies are underway to determine more precisely the role of TNF-α in host protection to B. mallei.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: bartonella melophagi (candidatus bartonella melophagi) (aka bartonella melophagi)
B: erysiphe malloti
C: modicella malleola (endogone malleola) (aka modicella malleola)
D: malleco
E: actinobacillus mallei (aka burkholderia mallei)
F: None of the above. | [E] |
<Instruct>: Given the context 'Multiple innate and adaptive cell types may contribute to the production of IFN-γ in response to infection with B. mallei following vaccination.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: erysiphe malloti
B: modicella malleola (endogone malleola) (aka modicella malleola)
C: mallomonas papillosa
D: malleco
E: actinobacillus mallei (aka burkholderia mallei)
F: None of the above. | [E] |
<Instruct>: Given the context 'The effector role for IFN-γ in mediating protection against B. mallei may include both immunoregulatory and non-regulatory functions.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleomyces pseudomallei (aka burkholderia pseudomallei)
B: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
C: acinetobacter mallei (aka burkholderia mallei)
D: bartonella melophagi (candidatus bartonella melophagi) (aka bartonella melophagi)
E: modicella malleola (endogone malleola) (aka modicella malleola)
F: None of the above. | [C] |
<Instruct>: Given the context 'Regardless, the requirement of IFN-γ, as demonstrated by administration of neutralizing antibody prior to infection, indicates that stimulation of IFN-γ response is a desirable goal for a B. mallei vaccine.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleco
B: mucilaginibacter mallensis
C: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
D: pfeifferella mallei (aka burkholderia mallei)
E: mallomonas papillosa
F: None of the above. | [D] |
<Instruct>: Given the context 'Similarly, B220-positive cells appear to play a role in protection following vaccination with heat-killed B. mallei.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: modicella malleola (endogone malleola) (aka modicella malleola)
B: pseudomonas mallei (aka burkholderia mallei)
C: 'bartonella melophagi' (aka bartonella melophagi)
D: malleco
E: mucilaginibacter mallensis
F: None of the above. | [B] |
<Instruct>: Given the context 'Protection against B. pseudomallei infection by anti-LPS, capsular polysaccharide and proteins has been short-lived, suggesting that antibody production offers limited protection in the initial stages of infection by an as-yet-undefined mechanism [12].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: burkholderia pseudomallei cb (burkholderia pseudomallei strain cb) (aka burkholderia pseudomallei cb)
B: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
C: burkholderia pseudomallei 6(1960)
D: burkholderia pseudomallei-like species (aka burkholderia thailandensis)
E: pseudomonas pseudomallei (aka burkholderia pseudomallei)
F: None of the above. | [E] |
<Instruct>: Given the context 'Protection against B. pseudomallei infection by anti-LPS, capsular polysaccharide and proteins has been short-lived, suggesting that antibody production offers limited protection in the initial stages of infection by an as-yet-undefined mechanism [12].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: burkholderia pseudomallei-like species (aka burkholderia thailandensis)
B: burkholderia pseudomallei cb (burkholderia pseudomallei strain cb) (aka burkholderia pseudomallei cb)
C: burkholderia pseudomallei 6(1960)
D: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
E: None of the above. | [E] |
<Instruct>: Given the context 'We have shown that following depletion of B220+ cells, survival rates decreased as much as 100% relative to non-depleted controls and individual CD4/CD8-depleted mice via the intraperitoneal route.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mice (aka mus <genus>) (aka mus <genus>)
B: mus domesticus (aka mus musculus domesticus)
C: house mouse (aka mus musculus)
D: mus sp. (mice (aka mus sp.))
E: mus castaneus (aka mus musculus castaneus)
F: None of the above. | [C] |
<Instruct>: Given the context 'Results from C57BL/6 mice deficient in mature B-cells (μMT), CD4 T-cells (CD4-/-) or CD8 T-cells (CD8-/-) substantiate the requirement for B-cell involvement by evidence of μMT and CD4-/- decreased survival.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus sp. (mice (aka mus sp.))
B: mus musculus (house mouse) (aka mus musculus)
C: mus (aka mus <genus>) (aka mus <genus>)
D: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
E: peromyscus
F: None of the above. | [B] |
<Instruct>: Given the context 'In CD4-deficient mice, we have the additional potential variable that a CD4-dependent antibody response might also be inhibited during the vaccination phase relative to mice treated with antibody immediately prior to and during the early phases of infection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus castaneus (aka mus musculus castaneus)
B: mus (aka mus <subgenus>) (aka mus <subgenus>)
C: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
D: mus musculus (house mouse) (aka mus musculus)
E: mice (aka mus sp.) (aka mus sp.)
F: None of the above. | [D] |
<Instruct>: Given the context 'Although not statistically significant, we did observe a decrease in survival in μMT (mature B cell) deficient mice as early as day 9 post challenge, whereas CD4-deficient mice produced similar results at day 32 post challenge, indicating a role for B cells independent of CD4 T cell help, perhaps through a T-independent mechanism of antibody production.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
B: mus cricetus (aka cricetus cricetus)
C: house mouse (aka mus musculus)
D: mice (aka mus sp.) (aka mus sp.)
E: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
F: None of the above. | [C] |
<Instruct>: Given the context 'Although CD8-/- C57BL/6 demonstrated no decreased survival in our HK-vaccinated model, a lack of potential endogenous protein production by HK B. mallei may have contributed to limited MHC-I presentation.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mallomonas papillosa
B: mallomonas peronoides (aka mallomonas peroneides)
C: pseudomonas mallei (aka burkholderia mallei)
D: inocybe subg. mallocybe (aka mallocybe)
E: erysiphe malloti
F: None of the above. | [C] |
<Instruct>: Given the context 'Complement associated studies revealed increased J774A.1 uptake of serum-treated B. mallei.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mucilaginibacter mallensis
B: malleco
C: erysiphe malloti
D: actinobacillus mallei (aka burkholderia mallei)
E: 'bartonella melophagi' (aka bartonella melophagi)
F: None of the above. | [D] |
<Instruct>: Given the context 'Complement-mediated uptake studies of B. pseudomallei by polymorphonuclear leukocytes (PMNs) suggest that capsule production contributes to resistance of phagocytosis by reducing C3b bacterial deposition', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. pseudomallei]
<Options>: A: pseudomonas pseudomallei (aka burkholderia pseudomallei)
B: burkholderia pseudomallei cs (burkholderia pseudomallei strain cs) (aka burkholderia pseudomallei cs)
C: pseudomallei group
D: burkholderia pseudomallei cms (burkholderia pseudomallei strain cms) (aka burkholderia pseudomallei cms)
E: burkholderia pseudomallei cb (burkholderia pseudomallei strain cb) (aka burkholderia pseudomallei cb)
F: None of the above. | [A] |
<Instruct>: Given the context 'Previous studies have demonstrated that a polysaccharide capsule is present in B. mallei, [14,15] although in the present study enhanced uptake with serum-treated B. mallei was observed.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: actinobacillus mallei (aka burkholderia mallei)
B: malleco
C: modicella malleola (endogone malleola) (aka modicella malleola)
D: malleomyces pseudomallei (aka burkholderia pseudomallei)
E: erysiphe malloti
F: None of the above. | [A] |
<Instruct>: Given the context 'Previous reports have demonstrated the ability of B. mallei to survive within macrophage without the aid of serum coating organisms [16].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mallomonas papillosa
B: loefferella mallei (aka burkholderia mallei)
C: mallocybe (inocybe subg. mallocybe) (aka mallocybe)
D: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
E: bartonella melophagi (candidatus bartonella melophagi) (aka bartonella melophagi)
F: None of the above. | [B] |
<Instruct>: Given the context 'The current results suggest that cobra venom factor treatment may affect the modulation of the immune response to B. mallei infection through B cell activation and/or memory B cell generation.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
B: malleco
C: modicella malleola (endogone malleola) (aka modicella malleola)
D: inocybe subg. mallocybe (aka mallocybe)
E: erysiphe malloti
F: None of the above. | [A] |
<Instruct>: Given the context 'The current results suggest that cobra venom factor treatment may affect the modulation of the immune response to B. mallei infection through B cell activation and/or memory B cell generation.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: inocybe subg. mallocybe (aka mallocybe)
B: malleco
C: modicella malleola (endogone malleola) (aka modicella malleola)
D: erysiphe malloti
E: None of the above. | [E] |
<Instruct>: Given the context 'Conclusion
In summary, our results provide a basis for future studies of protection via vaccination using either subunit or whole-organism vaccine preparations from lethal infection in the experimental BALB/c mouse model.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
B: mus <genus> (mice (aka mus <genus>))
C: house mouse (aka mus musculus)
D: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
E: mus (aka mus <subgenus>) (aka mus <subgenus>)
F: None of the above. | [C] |
<Instruct>: Given the context 'Understanding and defining the role of B cells in adaptive B. mallei immunity will likely be fundamental to the design of an efficacious vaccine and important goals of future research.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mallomonas papillosa
B: pseudomonas mallei (aka burkholderia mallei)
C: erysiphe malloti
D: 'bartonella melophagi' (aka bartonella melophagi)
E: mucilaginibacter mallensis
F: None of the above. | [B] |
<Instruct>: Given the context 'Methods
Bacterial strain and mice
B. mallei strain ATCC 23344 (China 7) was cultured on Luria-Bertani agar supplemented with 4% glycerol (LB+4%G) agar plates for 48 h at 37°C.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: malleco
B: peromyscus
C: erysiphe malloti
D: malleomyces pseudomallei (aka burkholderia pseudomallei)
E: mus cricetus (aka cricetus cricetus)
F: mallomonas peroneides (mallomonas peronoides) (aka mallomonas peroneides)
G: pfeifferella mallei (aka burkholderia mallei)
H: house mouse (aka mus musculus)
I: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
J: mice (aka mus sp.) (aka mus sp.)
K: None of the above. | [H; G] |
<Instruct>: Given the context 'Methods
Bacterial strain and mice
B. mallei strain ATCC 23344 (China 7) was cultured on Luria-Bertani agar supplemented with 4% glycerol (LB+4%G) agar plates for 48 h at 37°C.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
B: mouse (aka mus musculus)
C: mallomonas peronoides (aka mallomonas peroneides)
D: mus castaneus (aka mus musculus castaneus)
E: western european house mouse (aka mus musculus domesticus)
F: mus (aka mus <genus>) (aka mus <genus>)
G: mallomonas papillosa
H: mucilaginibacter mallensis
I: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
J: malleco
K: None of the above. | [B; I] |
<Instruct>: Given the context 'The absence of live B. mallei organisms in the HK preparations was confirmed after plating 10% of the total inoculums (v/v) and incubating these at 37°C for 48 h.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mucilaginibacter mallensis
B: bacillus mallei (aka burkholderia mallei)
C: inocybe subg. mallocybe (aka mallocybe)
D: malleomyces pseudomallei (aka burkholderia pseudomallei)
E: mallomonas papillosa
F: None of the above. | [B] |
<Instruct>: Given the context 'Female, 6- to 8-week-old, BALB/c mice (n = 5–7) were obtained from Harlan Sprague Dawley, Inc. (Indianapolis, Indiana).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: house mouse (aka mus musculus)
B: mus domesticus (aka mus musculus domesticus)
C: mus sp. (mice (aka mus sp.))
D: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
E: mus (aka mus <genus>) (aka mus <genus>)
F: None of the above. | [A] |
<Instruct>: Given the context 'Female, 6- to 8-week-old, C57BL/6 mice deficient in mature B-cells (μMT), CD4 T-cells (CD4-/-) and CD8 T-cells (CD8-/-) and wild-type mice were obtained from The Jackson Laboratory (Bar Harbor, Maine).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: house mouse (aka mus musculus)
B: mus cricetus (aka cricetus cricetus)
C: mus castaneus (aka mus musculus castaneus)
D: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
E: mus <genus> (mice (aka mus <genus>))
F: None of the above. | [A] |
<Instruct>: Given the context 'Vaccination and challenge
BALB/c and C57BL/6 mice were grouped and vaccinated with 0.5 μg of HK B. mallei (without adjuvant) by i.p. injection using a 25-gauge syringe.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: pseudomonas mallei (aka burkholderia mallei)
C: mice (aka mus sp.) (aka mus sp.)
D: inocybe subg. mallocybe (aka mallocybe)
E: erysiphe malloti
F: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
G: malleomyces pseudomallei (aka burkholderia pseudomallei)
H: modicella malleola (endogone malleola) (aka modicella malleola)
I: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
J: mouse (aka mus musculus)
K: None of the above. | [J; B] |
<Instruct>: Given the context 'Vaccination and challenge
BALB/c and C57BL/6 mice were grouped and vaccinated with 0.5 μg of HK B. mallei (without adjuvant) by i.p. injection using a 25-gauge syringe.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice; b. mallei]
<Options>: A: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
B: mallomonas peronoides (aka mallomonas peroneides)
C: mice (aka mus <genus>) (aka mus <genus>)
D: peromyscus
E: modicella malleola (endogone malleola) (aka modicella malleola)
F: mus musculus (house mouse) (aka mus musculus)
G: mallomonas papillosa
H: malleco
I: mus domesticus (aka mus musculus domesticus)
J: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
K: None of the above. | [F; A] |
<Instruct>: Given the context 'Two weeks post HK vaccination mice were injected i.p.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mouse (aka mus musculus)
B: mus <genus> (mice (aka mus <genus>))
C: mice (aka mus sp.) (aka mus sp.)
D: mus <subgenus> (mus (aka mus <subgenus>))
E: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
F: None of the above. | [A] |
<Instruct>: Given the context 'with 2 × 107 CFU/100 μl of live B. mallei (~20 LD50)', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: mucilaginibacter mallensis
B: malleco
C: erysiphe malloti
D: 'bartonella melophagi' (aka bartonella melophagi)
E: pseudomonas mallei (aka burkholderia mallei)
F: None of the above. | [E] |
<Instruct>: Given the context 'Cell and cytokine depletions
Acute in vivo cell/cytokine depletion was performed with monoclonal rat anti-mouse CD4 (GK1.5), CD8α (53-6.7) or B220 (RA3-6B2) obtained from R&D Systems, Inc. (Minneapolis, MN) by methods similar to those we have previously described [19].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: black rat (aka rattus rattus)
B: rattus norvegicus albus
C: rats (aka rattus sp.) (aka rattus sp.)
D: mouse (aka mus musculus)
E: mus molossinus (aka mus musculus molossinus)
F: mus cricetus (aka cricetus cricetus)
G: rat (aka rattus norvegicus) (aka rattus norvegicus)
H: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
I: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
J: mus sp. (mice (aka mus sp.))
K: None of the above. | [G; D] |
<Instruct>: Given the context 'Cell and cytokine depletions
Acute in vivo cell/cytokine depletion was performed with monoclonal rat anti-mouse CD4 (GK1.5), CD8α (53-6.7) or B220 (RA3-6B2) obtained from R&D Systems, Inc. (Minneapolis, MN) by methods similar to those we have previously described [19].', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: rattus sp. (rats (aka rattus sp.))
B: peromyscus
C: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
D: eastern european house mouse (aka mus musculus musculus)
E: rattus norvegicus albus
F: mus (aka mus <subgenus>) (aka mus <subgenus>)
G: house mouse (aka mus musculus)
H: norway rat (aka rattus norvegicus)
I: rats (aka rattus) (aka rattus)
J: mus molossinus (aka mus musculus molossinus)
K: None of the above. | [H; G] |
<Instruct>: Given the context 'Functional grade purified rat anti-mouse interferon-gamma (IFN-γ, AN-18) was obtained from eBioscience (San Diego, CA) and purified anti-mouse tumor necrosis factor (TNF-α, MP6-XT3) from BD Pharmingen (San Diego, CA).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
B: mus <genus> (mice (aka mus <genus>))
C: mice (aka mus sp.) (aka mus sp.)
D: rattus norvegicus albus
E: black rat (aka rattus rattus)
F: rats (aka rattus norvegicus) (aka rattus norvegicus)
G: rattus (rats (aka rattus))
H: mouse (aka mus musculus)
I: rattus sp. (rats (aka rattus sp.))
J: mus <subgenus> (mus (aka mus <subgenus>))
K: None of the above. | [F; H] |
<Instruct>: Given the context 'Functional grade purified rat anti-mouse interferon-gamma (IFN-γ, AN-18) was obtained from eBioscience (San Diego, CA) and purified anti-mouse tumor necrosis factor (TNF-α, MP6-XT3) from BD Pharmingen (San Diego, CA).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: mus rattus (aka rattus rattus)
B: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
C: brown rat (aka rattus norvegicus)
D: eastern european house mouse (aka mus musculus musculus)
E: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
F: peromyscus
G: mus musculus domesticus (western european house mouse) (aka mus musculus domesticus)
H: house mouse (aka mus musculus)
I: rattus norvegicus albus
J: rats (aka rattus sp.) (aka rattus sp.)
K: None of the above. | [C; H] |
<Instruct>: Given the context 'IFN-γ and TNF-α antibodies were injected i.p. 6 h prior to challenge, 200 μg per mouse in 200 μl PBS or at later time points as indicated.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus (aka mus <subgenus>) (aka mus <subgenus>)
B: mice (aka mus sp.) (aka mus sp.)
C: house mouse (aka mus musculus)
D: mus molossinus (aka mus musculus molossinus)
E: mus cricetus (aka cricetus cricetus)
F: None of the above. | [C] |
<Instruct>: Given the context 'Rat IgG isotype control was obtained from Southern Biotech (Birmingham, AL) and administered i.p.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat]
<Options>: A: rattus norvegicus albus
B: brown rat (aka rattus norvegicus)
C: roof rat (aka rattus rattus)
D: rattus (rats (aka rattus))
E: rattus rattoides (aka rattus pyctoris)
F: None of the above. | [B] |
<Instruct>: Given the context 'on day of challenge, 200 μg/mouse.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus cricetus (aka cricetus cricetus)
B: mouse (aka mus musculus)
C: eastern european house mouse (aka mus musculus musculus)
D: peromyscus
E: mice (aka mus <genus>) (aka mus <genus>)
F: None of the above. | [B] |
<Instruct>: Given the context 'Rat anti-mouse CD4, CD8α and B220 were injected i.p. twice, 1 day prior to challenge and on day of challenge, with an equivalent dosage sufficient to deplete T or B cells from 6 × 108 bone marrow cells per injection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: mus musculus (house mouse) (aka mus musculus)
B: norway rat (aka rattus norvegicus)
C: mus <subgenus> (mus (aka mus <subgenus>))
D: rattus norvegicus albus
E: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
F: mus domesticus (aka mus musculus domesticus)
G: peromyscus
H: rats (aka rattus sp.) (aka rattus sp.)
I: rattus rattoides (aka rattus pyctoris)
J: black rat (aka rattus rattus)
K: None of the above. | [B; A] |
<Instruct>: Given the context 'Rat anti-mouse CD4, CD8α and B220 were injected i.p. twice, 1 day prior to challenge and on day of challenge, with an equivalent dosage sufficient to deplete T or B cells from 6 × 108 bone marrow cells per injection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: peromyscus
B: rats (aka rattus sp.) (aka rattus sp.)
C: mus molossinus (aka mus musculus molossinus)
D: mus (aka mus <subgenus>) (aka mus <subgenus>)
E: mus rattus (aka rattus rattus)
F: western european house mouse (aka mus musculus domesticus)
G: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
H: mus norvegicus (aka rattus norvegicus)
I: mus musculus (house mouse) (aka mus musculus)
J: rat (aka rattus) (aka rattus)
K: None of the above. | [H; I] |
<Instruct>: Given the context 'Rat anti-mouse CD4, CD8α and B220 were injected i.p. twice, 1 day prior to challenge and on day of challenge, with an equivalent dosage sufficient to deplete T or B cells from 6 × 108 bone marrow cells per injection.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: rat (aka rattus) (aka rattus)
B: mus molossinus (aka mus musculus molossinus)
C: rattus pyctoris (rattus rattoides) (aka rattus pyctoris)
D: mus rattus (aka rattus rattus)
E: rats (aka rattus sp.) (aka rattus sp.)
F: mus norvegicus (aka rattus norvegicus)
G: mus (aka mus <subgenus>) (aka mus <subgenus>)
H: western european house mouse (aka mus musculus domesticus)
I: peromyscus
J: None of the above. | [F; J] |
<Instruct>: Given the context 'Complement depletion with cobra venom factor
Mice, six to seven per group, were vaccinated i.p.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus sp. (mice (aka mus sp.))
B: mus castaneus (aka mus musculus castaneus)
C: mus (aka mus <subgenus>) (aka mus <subgenus>)
D: house mouse (aka mus musculus)
E: peromyscus
F: None of the above. | [D] |
<Instruct>: Given the context 'with 1 × 105 CFU of nonviable B. mallei cell preparation in a total volume of 0.1 ml.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleomyces pseudomallei (aka burkholderia pseudomallei)
B: burkholderia mallei (actinobacillus mallei) (aka burkholderia mallei)
C: mucilaginibacter mallensis
D: 'bartonella melophagi' (aka bartonella melophagi)
E: inocybe subg. mallocybe (aka mallocybe)
F: None of the above. | [B] |
<Instruct>: Given the context 'Two weeks later, 24 h and 1 h before challenge, complement depleted mice were treated i.p. with 12.5 units total cobra venom factor (Quidel Corporation Speciality Products, San Diego, CA) in 0.1 ml of PBS.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus <genus> (mice (aka mus <genus>))
B: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
C: mus cricetus (aka cricetus cricetus)
D: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
E: house mouse (aka mus musculus)
F: None of the above. | [E] |
<Instruct>: Given the context 'Complement depletion was confirmed prior to challenge by micro-titer hemolytic complement activity (CH50) assay as previously described [20].
B. mallei J774A.1 uptake assays
J774A.1 cells were seeded (5 × 105) onto Corning costar 24 well plates (Corning, NY) with DMEM and incubated overnight at 37°C with 5% CO2.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: loefferella mallei (aka burkholderia mallei)
B: erysiphe malloti
C: modicella malleola (endogone malleola) (aka modicella malleola)
D: malleomyces pseudomallei (aka burkholderia pseudomallei)
E: 'bartonella melophagi' (aka bartonella melophagi)
F: None of the above. | [A] |
<Instruct>: Given the context 'Bacterial suspensions were incubated at 37°C for 45 minutes supplemented with 2% mouse serum from Sigma-Aldrich (St. Louis, MO.), heat inactivated mouse serum (56°C 30 minutes), or bacteria alone and then added at an MOI of 10:1 to J774A.1 cells in triplicate.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus <genus> (mice (aka mus <genus>))
B: mus molossinus (aka mus musculus molossinus)
C: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
D: mouse (aka mus musculus)
E: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
F: None of the above. | [D] |
<Instruct>: Given the context 'Antibodies used for analysis of surface markers included: FITC-conjugated rat anti-mouse CD45R/B220 (RA3-6B2, BD Pharmingen San Diego, CA) for B cells; FITC-conjugated rat anti-mouse CD8α (53-6.7) and CD4 (GK1.5, BD Pharmingen, San Diego, CA) for CD8+ or CD4+ cells, respectively.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: rattus sp. (rats (aka rattus sp.))
B: mus molossinus (aka mus musculus molossinus)
C: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
D: mus <subgenus> (mus (aka mus <subgenus>))
E: mouse (aka mus musculus)
F: rat (aka rattus norvegicus) (aka rattus norvegicus)
G: rats (aka rattus) (aka rattus)
H: rattus rattoides (aka rattus pyctoris)
I: rattus rattoides (aka rattus rattus)
J: mus cricetus (aka cricetus cricetus)
K: None of the above. | [F; E] |
<Instruct>: Given the context 'Antibodies used for analysis of surface markers included: FITC-conjugated rat anti-mouse CD45R/B220 (RA3-6B2, BD Pharmingen San Diego, CA) for B cells; FITC-conjugated rat anti-mouse CD8α (53-6.7) and CD4 (GK1.5, BD Pharmingen, San Diego, CA) for CD8+ or CD4+ cells, respectively.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [rat; mouse]
<Options>: A: western european house mouse (aka mus musculus domesticus)
B: peromyscus
C: rattus sp. (rats (aka rattus sp.))
D: rattus rattoides (aka rattus pyctoris)
E: mouse (aka mus musculus)
F: mus rattus (aka rattus rattus)
G: mus cricetus (aka cricetus cricetus)
H: rat (aka rattus norvegicus) (aka rattus norvegicus)
I: rattus norvegicus albus
J: mus molossinus (aka mus musculus molossinus)
K: None of the above. | [H; E] |
<Instruct>: Given the context 'Samples evaluated for CD4+ and CD8α+ cells were also incubated with biotin-conjugated hamster anti-mouse CD3e (145-2C11) monoclonal antibody (BD Pharmingen, San Diego, CA) and subsequently with streptavidin APC Cy7.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
B: peromyscus
C: mus musculus (house mouse) (aka mus musculus)
D: mus cricetus (aka cricetus cricetus)
E: mice (aka mus sp.) (aka mus sp.)
F: None of the above. | [C] |
<Instruct>: Given the context 'Samples evaluated for CD4+ and CD8α+ cells were also incubated with biotin-conjugated hamster anti-mouse CD3e (145-2C11) monoclonal antibody (BD Pharmingen, San Diego, CA) and subsequently with streptavidin APC Cy7.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
B: mus cricetus (aka cricetus cricetus)
C: mice (aka mus sp.) (aka mus sp.)
D: peromyscus
E: None of the above. | [E] |
<Instruct>: Given the context 'Antibody assays
Immunoglobulin subclass IgG1 and IgG2a titers in mice were determined by a whole bacterial cell ELISA performed in 96-well, Immulon 2 HB, round-bottom plates (Dynex Technologies).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mice]
<Options>: A: mus (aka mus <subgenus>) (aka mus <subgenus>)
B: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
C: mus sp. (mice (aka mus sp.))
D: house mouse (aka mus musculus)
E: mouse (aka mus <genus>)
F: None of the above. | [D] |
<Instruct>: Given the context 'B. mallei antigen was diluted in 0.1 M carbonate buffer (pH 9.5) and 50 μl of diluted cells placed into wells.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b. mallei]
<Options>: A: malleomyces pseudomallei (aka burkholderia pseudomallei)
B: erysiphe malloti
C: bacillus mallei (aka burkholderia mallei)
D: inocybe subg. mallocybe (aka mallocybe)
E: modicella malleola (endogone malleola) (aka modicella malleola)
F: None of the above. | [C] |
<Instruct>: Given the context 'The plates were washed with washing solution (1× PBS, 0.05% Tween 20), and incubated with 100 μl of blocking solution (1× PBS, 1% bovine serum albumin, 0.05% Tween 20) for 1 h at 37°C.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bovine]
<Options>: A: bovinae
B: bos sp.
C: cattle (aka bos)
D: bos taurus x bos indicus (aka bos indicus x bos taurus)
E: domestic cow (aka bos taurus)
F: None of the above. | [E] |
<Instruct>: Given the context 'Dilutions of mouse sera were made with blocking solution in duplicate and plates were incubated for 1 h at 37°C.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mouse]
<Options>: A: mus <genus> (mice (aka mus <genus>))
B: mouse (aka mus musculus)
C: mus musculoides (mus musculoides enclavae) (aka mus musculoides)
D: peromyscus
E: mus musculus musculus (eastern european house mouse) (aka mus musculus musculus)
F: None of the above. | [B] |
<Instruct>: Given the context 'Following incubation, plates were washed and 50 μl of anti-Ig-horseradish peroxidase subclass conjugate, diluted accordingly to manufacturer's instructions (Southern Biotechnology Associates, Inc.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [horseradish]
<Options>: A: hydnum canadense
B: rosa virginiana
C: horseradish (aka armoracia rusticana)
D: rosa alba (aka rosa x alba)
E: randia ferox (gardenia ferox) (aka randia ferox)
F: None of the above. | [C] |
<Instruct>: Given the context 'Mapping irradiation hybrids to cosmid and yeast artificial chromosome libraries by direct hybridization of Alu-PCR products.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: saccharomyces sp.
B: brewer's yeast (aka saccharomyces cerevisiae)
C: candida/saccharomycetales (aka candida/saccharomycales clade)
D: saccharomyces cerevisiae x saccharomyces mikatae
E: saccharomyces cf. cerevisiae
F: None of the above. | [B] |
<Instruct>: Given the context 'Abstract
A direct hybridization protocol is described for screening cosmid and yeast artificial chromosome libraries with pools of Alu-PCR products from somatic cell or irradiation hybrids.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: saccharomyces cerevisiae or paradoxus (aka saccharomyces cf. cerevisiae/paradoxus)
B: saccharomycetes (hemiascomycetes) (aka saccharomycetes)
C: candida/saccharomycetales (aka candida/saccharomycales clade)
D: brewer's yeast (aka saccharomyces cerevisiae)
E: saccharomyces sp.
F: None of the above. | [D] |
<Instruct>: Given the context 'A series of human X chromosome irradiation hybrids were mapped by this method, using a cosmid reference library for comparisons between overlapping hybrids to identify interesting clones for further analysis.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: species
B: primate (aka primates)
C: human (aka homo sapiens)
D: homo (humans) (aka homo)
E: birds (aka aves)
F: None of the above. | [C] |
<Instruct>: Given the context 'Images
Nucleic Acids Research, Vol. 19, No. 12 3315
Mapping irradiation hybrids to cosmid and yeast artificial chromosome libraries by direct hybridization of Alu-PCR products
Anthony P.Monaco*, Veronica M.S.Lam2, Gunther Zehetner, Gregory G.Lennon, Christal Douglas, Dean Nizetic, Peter N.Goodfellow1 and Hans Lehrach
Genome Analysis Laboratory and 'Molecular Human Genetics Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK and 2Department of Biochemistry, Li Shu Fan Building, Sassoon Road, University of Hong Kong, Hong Kong
Received March 12, 1991; Revised and Accepted May 16, 1991
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: saccharomyces cerevisiae (desm.) meyen ex e.c. hansen, 1883 (aka saccharomyces cerevisiae)
B: saccharomyces albicans (aka candida albicans)
C: saccharomycetes (hemiascomycetes) (aka saccharomycetes)
D: saccharomyces sp.
E: saccharomyces cerevisiae x saccharomyces mikatae
F: None of the above. | [A] |
<Instruct>: Given the context 'ABSTRACT
A direct hybridization protocol is described for screening cosmid and yeast artificial chromosome libraries with pools of Alu-PCR products from somatic cell or irradiation hybrids.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: saccharomyces albicans (aka candida albicans)
B: saccharomyces cf. cerevisiae
C: saccharomyces cerevisiae x saccharomyces mikatae
D: brewer's yeast (aka saccharomyces cerevisiae)
E: saccharomycodes
F: None of the above. | [D] |
<Instruct>: Given the context 'ABSTRACT
A direct hybridization protocol is described for screening cosmid and yeast artificial chromosome libraries with pools of Alu-PCR products from somatic cell or irradiation hybrids.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [yeast]
<Options>: A: saccharomycodes
B: saccharomyces cerevisiae x saccharomyces mikatae
C: saccharomyces albicans (aka candida albicans)
D: saccharomyces cf. cerevisiae
E: None of the above. | [E] |
<Instruct>: Given the context 'A series of human X chromosome irradiation hybrids were mapped by this method, using a cosmid reference library for comparisons between overlapping hybrids to identify interesting clones for further analysis.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: avian (aka aves)
B: primate (aka primates)
C: human (aka homo sapiens)
D: placental mammals (aka eutheria)
E: genus
F: None of the above. | [C] |
<Instruct>: Given the context 'INTRODUCTION
The generation of human DNA probes specific for individual chromosomes and subregions of chromosomes has been advanced with Alu-sequence primed polymerase chain reaction amplification (Alu-PCR, 1-3).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: this
B: primate (aka primates)
C: animals (aka metazoa)
D: suborder
E: homo sapiens (human) (aka homo sapiens)
F: None of the above. | [E] |
<Instruct>: Given the context 'This method specifically amplifies sequences between Alu repeats from human DNA in somatic cell hybrids and yeast artificial chromosomes (YACs, 4).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; yeast]
<Options>: A: genus
B: kingdom
C: saccharomyces cf. cerevisiae
D: placental mammals (aka eutheria)
E: baker's yeast (aka saccharomyces cerevisiae)
F: homo (humans) (aka homo)
G: saccharomycodes
H: saccharomyces sp.
I: human (aka homo sapiens)
J: saccharomycetes (hemiascomycetes) (aka saccharomycetes)
K: None of the above. | [I; E] |
<Instruct>: Given the context 'This method specifically amplifies sequences between Alu repeats from human DNA in somatic cell hybrids and yeast artificial chromosomes (YACs, 4).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human; yeast]
<Options>: A: animals (aka metazoa)
B: saccharomyces cerevisiae or paradoxus (aka saccharomyces cf. cerevisiae/paradoxus)
C: saccharomyces hansenii (aka debaryomyces hansenii)
D: genus
E: saccharomyces sp.
F: baker's yeast (aka saccharomyces cerevisiae)
G: kingdom
H: saccharomyceta
I: human (aka homo sapiens)
J: suborder
K: None of the above. | [I; F] |
<Instruct>: Given the context 'Two new human specific Alu primers were used to generate DNA probes from a series of irradiation-reduced hybrids containing multiple human X chromosome fragments of 1-2000 kb on a hamster chromosome background (5; P.N.G., unpublished).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: animals (aka metazoa)
B: suborder
C: avian (aka aves)
D: this
E: human (aka homo sapiens)
F: None of the above. | [E] |
<Instruct>: Given the context 'The Alu-PCR products were hybridized as a pool of probes to X-specific cosmid and YAC libraries, after
competitive reassociation with an excess of human DNA to both the library filters and radioactively labelled Alu-PCR products.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: macrobiotus sapiens
B: animals (aka metazoa)
C: human (aka homo sapiens)
D: this
E: genus
F: None of the above. | [C] |
<Instruct>: Given the context 'METHODS
Two human Alu sequence primers were generated which were shown to be human specific; 3144 from the 3' end of Alu: 5'-GAGCGAGACTCCGTCTCAAA-3' and 2729 from the 5' end of Alu: 5'-GTGGATCACCTGAGGTCAGGAGTTC-3'.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: suborder
B: placental mammals (aka eutheria)
C: animals (aka metazoa)
D: human (aka homo sapiens)
E: kingdom
F: None of the above. | [D] |
<Instruct>: Given the context 'Chinese hamster DNA and no DNA PCR reactions were done to control for non-human products (data not shown).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [chinese hamster; human]
<Options>: A: biota (aka cellular organisms)
B: this
C: golden hamster (aka mesocricetus auratus)
D: human (aka homo sapiens)
E: suborder
F: hamsters (aka cricetinae)
G: chinese hamster (aka cricetulus griseus)
H: kingdom
I: ciscaucasian hamster (aka mesocricetus raddei)
J: turkish hamster (aka mesocricetus brandti)
K: None of the above. | [G; D] |
<Instruct>: Given the context 'Chinese hamster DNA and no DNA PCR reactions were done to control for non-human products (data not shown).
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [chinese hamster; human]
<Options>: A: primate (aka primates)
B: golden hamsters (aka mesocricetus auratus)
C: macrobiotus sapiens
D: black-bellied hamster (aka cricetus cricetus)
E: chinese hamster (aka cricetulus griseus)
F: suborder
G: species
H: ciscaucasian hamster (aka mesocricetus raddei)
I: homo sapiens (human) (aka homo sapiens)
J: turkish hamster (aka mesocricetus brandti)
K: None of the above. | [E; I] |
<Instruct>: Given the context 'The radioactively labelled pool of fragments was prehybridized with 37.5 ,^g of total human DNA and 12.5 tsg of hamster DNA immobilized on a cellulose support matrix, prepared as previously described (7).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [human]
<Options>: A: animals (aka metazoa)
B: suborder
C: probles
D: human (aka homo sapiens)
E: biota (aka cellular organisms)
F: None of the above. | [D] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.